Literature DB >> 17255802

Long-term continuous oxygen treatment in chronic obstructive pulmonary disease: proper use, benefits and unresolved issues.

Philip O'Reilly1, William Bailey.   

Abstract

PURPOSE OF REVIEW: Long-term oxygen treatment is one of the few interventions that improve survival in chronic obstructive pulmonary disease and it is widely used even though published evidence supporting the use of this treatment in chronic obstructive pulmonary disease is scanty. In addition, some studies do not demonstrate a mortality benefit for long-term oxygen treatment in this disease. It is important that long-term oxygen treatment be administered only to those patients who will benefit and in a manner that maximizes its efficacy. New studies are urgently needed to address these questions. RECENT
FINDINGS: The published evidence for and against the use of long-term oxygen treatment in chronic obstructive pulmonary disease is summarized and problems with current guidelines and important areas for future research are discussed.
SUMMARY: Future research will address the optimal timing and duration of oxygen therapy during rest, exercise and sleep, ways of identifying chronic obstructive pulmonary disease patients who are most likely to benefit and ways of improving patient compliance, all of which may have a profound effect on clinical practice.

Entities:  

Mesh:

Year:  2007        PMID: 17255802     DOI: 10.1097/MCP.0b013e32802c7cfe

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  5 in total

1.  Chronic obstructive pulmonary disease: a view from the NHLBI.

Authors:  Antonello Punturieri; Thomas L Croxton; Gail G Weinmann; James P Kiley
Journal:  Am J Respir Crit Care Med       Date:  2008-09-01       Impact factor: 21.405

2.  The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats.

Authors:  Jing Feng; Qing-shan Wang; Ambrose Chiang; Bao-yuan Chen
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

3.  Integrated transcriptomic response to cardiac chronic hypoxia: translation regulators and response to stress in cell survival.

Authors:  Dumitru A Iacobas; Chenhao Fan; Sanda Iacobas; Gabriel G Haddad
Journal:  Funct Integr Genomics       Date:  2008-05-01       Impact factor: 3.410

Review 4.  Treatment of respiratory failure in COPD.

Authors:  Stephan Budweiser; Rudolf A Jörres; Michael Pfeifer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

5.  Changes in blood hemoglobin and blood gases PaO2 and PaCO2 in severe COPD overa three-year telemonitored program of long-term oxygen treatment.

Authors:  Roberto W Dal Negro; Silvia Tognella; Luca Bonadiman; Paola Turco
Journal:  Multidiscip Respir Med       Date:  2012-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.